| SC 13G | 2019-01-31 | VANGUARD SPECIALIZED FUNDS | INCYTE CORP | 11,113,220 | 5.2% | EDGAR |
| SC 13D/A | 2018-05-03 | BAKER BROS. ADVISORS LP | INCYTE CORP | 34,410,751 | 16.2% | EDGAR |
| SC 13G/A | 2018-02-14 | Capital World Investors | INCYTE CORP | 6,136,224 | 2.9% | EDGAR |
| SC 13G | 2018-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | INCYTE CORP | 14,812,315 | 7.0% | EDGAR |
| SC 13G/A | 2018-02-09 | VANGUARD GROUP INC | INCYTE CORP | 17,997,955 | 8.5% | EDGAR |
| SC 13G/A | 2018-02-08 | WELLINGTON MANAGEMENT GROUP LLP | INCYTE CORP | 13,549,792 | 6.4% | EDGAR |
| SC 13G/A | 2018-02-02 | VANGUARD SPECIALIZED FUNDS | INCYTE CORP | 9,466,973 | 4.5% | EDGAR |
| SC 13G/A | 2018-01-25 | BlackRock Inc. | INCYTE CORP | 14,291,645 | 6.8% | EDGAR |
| SC 13D/A | 2017-04-28 | BAKER BROS. ADVISORS LP | INCYTE CORP | 34,295,011 | 16.7% | EDGAR |
| SC 13D/A | 2017-02-22 | BAKER JULIAN | INCYTE CORP | 34,279,869 | 16.9% | EDGAR |
| SC 13G/A | 2017-02-14 | INCYTE CORP | AGENUS INC | 17,763,968 | 18.1% | EDGAR |
| SC 13G/A | 2017-02-13 | VANGUARD SPECIALIZED FUNDS | INCYTE CORP | 11,635,908 | 6.2% | EDGAR |
| SC 13G/A | 2017-02-13 | Capital World Investors | INCYTE CORP | 10,301,491 | 5.4% | EDGAR |
| SC 13G/A | 2017-02-10 | VANGUARD GROUP INC | INCYTE CORP | 12,567,950 | 6.7% | EDGAR |
| SC 13G/A | 2017-02-09 | WELLINGTON MANAGEMENT GROUP LLP | INCYTE CORP | 18,072,696 | 9.6% | EDGAR |
| SC 13G | 2017-01-31 | INCYTE CORP | Calithera Biosciences, Inc. | 1,720,430 | 7.4% | EDGAR |
| SC 13G/A | 2017-01-25 | BlackRock Inc. | INCYTE CORP | 11,029,419 | 5.9% | EDGAR |
| SC 13G | 2017-01-23 | INCYTE CORP | Merus N.V. | 3,200,000 | 16.6% | EDGAR |
| SC 13G/A | 2016-12-12 | PRICE T ROWE ASSOCIATES INC /MD/ | INCYTE CORP | 7,702,496 | 4.0% | EDGAR |
| SC 13D/A | 2016-03-17 | BAKER JULIAN | INCYTE CORP | 23,653,198 | 12.7% | EDGAR |